October 2, 2022

Volume XII, Number 275

Wei Yan, Ph.D.

Wei brings an extensive technical background to his work in patent preparation and prosecution, freedom to operate analyses, patent landscaping, and due diligence. Wei is also a member of the FDA Regulatory practice group at Michael Best. His strong track record in patent and FDA regulatory matters for clients in the pharmaceutical, health, food, and agricultural industries is based on his diverse and in-depth knowledge of:

  • Organic chemistry

  • Pharmaceutical products

  • Health, nutrition and metabolic diseases

  • Bioanalytical and diagnostic tools

  • Mass spectrometry

  • Proteins and enzymes

  • Cellular signaling

  • Polymers

Articles in the National Law Review database by Wei Yan, Ph.D.